Simplex Trading’s Mustang Bio MBIO Stock Holding History

Simplex Trading’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Hold	0	–	–	–	9535
2023 Q1	–	Hold	0	–	–	–	9694
2022 Q3	–	Hold	0	–	–	–	10487
2022 Q2	–	Sell	-3	Closed	-$1.66K	–	10618
2022 Q1	$2K	Sell	3 -51	-94%	-$41.9K	﹤0.01%	9877
2021 Q4	$67K	Buy	54 +42	+350%	+$67.8K	﹤0.01%	6829
2021 Q3	$30K	Sell	12 -24	-67%	-$51.6K	﹤0.01%	8086
2021 Q2	$90K	Buy	36 +10	+38%	+$24.5K	﹤0.01%	6880
2021 Q1	$65K	Sell	26 -29	-53%	-$86.2K	﹤0.01%	6298
2020 Q4	$155K	Buy	55 +31	+129%	+$74.1K	﹤0.01%	4944
2020 Q3	$57K	Buy	+24	New	+$59.2K	﹤0.01%	5485
2020 Q2	–	Sell	-28	Closed	-$65.5K	–	8032
2020 Q1	$55K	Buy	+28	New	+$71.8K	﹤0.01%	5034
2019 Q4	–	Sell	-1	Closed	-$2.29K	–	7673
2019 Q3	$3K	Sell	1 -5	-83%	-$13.7K	﹤0.01%	6802
2019 Q2	$17K	Buy	+6	New	+$17.1K	﹤0.01%	5739

Other funds holding MBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Simplex Trading's MBIO Position: Q2 2023 in Review

Simplex Trading held its Mustang Bio (MBIO) position steady in Q2 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #9535.

Simplex Trading first reported a position in MBIO in Q2 2019 and has held it in 10 quarters since. The position peaked at $155K in Q4 2020. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

Simplex Trading held 0 shares of Mustang Bio worth $0 as of Q2 2023.
Simplex Trading left its Mustang Bio share count unchanged in Q2 2023.
Mustang Bio made up ﹤0.01% of Simplex Trading's portfolio in Q2 2023, its #9535 holding.
Simplex Trading first reported a position in Mustang Bio in Q2 2019 and has held it in 10 quarters since.
Simplex Trading's Mustang Bio position peaked at $155K in Q4 2020.
27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.